Brendan Halloran

Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept

Contact

Associate Professor, Faculty of Medicine & Dentistry - Medicine Dept
Email
brendan@ualberta.ca
Phone
(780) 492-8691

Overview

Area of Study / Keywords


About

Other positions I currently hold are:

  • Clinical Co-Director - Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR)
  • Program Director - Inflammatory Bowel Disease Fellowship Training Program
  • Co-Director - Small Bowel Endoscopy Program

Research

Improving treatment of patients with inflammatory bowel diseases (IBD)

  • Application of microarray technology to predict the outcome of IBD as well as a patient's response to therapies, such as infliximab, adalimumab, and vedolizumab. 

Small bowel endoscopy 

  • Double-balloon endoscopy is a relatively new technology that my team is assessing for the management of patients with Crohn's disease of the small bowel. 
  • Imaging of the entire intestinal tract provides insight into how the individual is responding to therapy and can inform treatment modifications. 

Epstein-Barr virus in IBD

Health economic assessments of biologic therapies for the treatment of IBD

Featured Publications

Canadian Digestive Disease Week. 2022 February; 10.1093/jcag/gwab049.115


Canadian Digestive Disease Week. 2022 February; 10.1093/jcag/gwab049.030


Canadian Digestive Disease Week. 2022 February; 10.1093/jcag/gwab049.092


Tandon P, Lee E, Jogendran R, Kroeker K, Dieleman L, Halloran B, Wong K, Berga K, Huang V

INFLAMMATORY BOWEL DISEASES. 2022 January; 10.1093/ibd/izab354


Balram B., Joshi H., Wong K., Kroeker K.I., Dieleman L.A., Halloran B.P., Baumgart D.C., Peerani F.

DIGESTIVE DISEASES AND SCIENCES. 2021 November; 66 (11):3985-3992 10.1007/s10620-020-06704-6


Halloran B.P., Jamil L.H., Lo S.K., Reeson M., Vasiliauskas E.A., Targan S., Ippoliti A., Mann N.K., Melmed G.Y.

INFLAMMATORY BOWEL DISEASES. 2021 August; 27 (8):1248-1255 10.1093/ibd/izaa287


Hu A., Kotze P.G., Burgevin A., Tan W., Jess A., Li P.S., Kroeker K., Halloran B., Panaccione R., Peyrin-Biroulet L., Ma C., Ananthakrishnan A.N.

Clinical Gastroenterology and Hepatology. 2021 July; 19 (7):1366-1376.e2 10.1016/j.cgh.2020.07.012


Taylor L.M., Eslamparast T., Farhat K., Kroeker K., Halloran B., Shommu N., Kumar A., Fitzgerald Q., Gramlich L., Abraldes J.G., Tandon P., Raman M.

Crohn's and Colitis 360. 2021 July; 3 (3) 10.1093/crocol/otab043


Tandon P., Lee E.Y., Maxwell C., Hitz L., Ambrosio L., Dieleman L., Halloran B., Kroeker K., Huang V.M.

DIGESTIVE DISEASES AND SCIENCES. 2021 May; 66 (5):1639-1649 10.1007/s10620-020-06381-5


Gastroenterology. 2021 May; 10.1016/S0016-5085(21)01040-4


Gastroenterology. 2021 May; 10.1016/S0016-5085(21)02383-0


Gastroenterology. 2021 May; 10.1016/S0016-5085(21)01043-X


MAJORITY OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH RECURRENT CLOSTRIDIOIDES INFECTION DO NOT REQUIRE FECAL MICROBIOTA TRANSPLANTATION

Journal of the Canadian Association of Gastroenterology. 2021 March;


Balram B., Joshi H., Wong K., Kroeker K.I., Dieleman L.A., Halloran B.P., Baumgart D.C., Peerani F.

DIGESTIVE DISEASES AND SCIENCES. 2020 November; 10.1007/s10620-020-06704-6


Halloran B.P., Jamil L.H., Lo S.K., Reeson M., Vasiliauskas E.A., Targan S., Ippoliti A., Mann N.K., Melmed G.Y.

Inflammatory Bowel Diseases. 2020 November; 27 (8):1248-1255 10.1093/ibd/izaa287